HomeGeneticsConditionsPeeling skin syndrome 2
Back to Conditions
Peeling skin syndrome 2
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Conditions

Peeling skin syndrome 2

Peeling skin syndrome 2 is a rare skin disorder characterized by the painless, spontaneous peeling of the top layer of the skin, particularly on the hands and feet.

Overview

Peeling skin syndrome 2 is a condition where the top layer of the skin peels away. This peeling is most apparent on the hands and feet, though it can occasionally affect the arms and legs. The condition typically begins shortly after birth, though it may start in childhood or later. While the underlying skin may be red and itchy, it generally heals without scarring, and the condition is not associated with other health problems.

Symptoms

  • Painless peeling of the epidermis (top layer of skin).
  • Peeling is exacerbated by heat, humidity, moisture, and friction.
  • Temporary redness and itching of the skin beneath the peeled area.

Causes

The disorder is caused by variants in the TGM5 gene, which provides instructions for making the enzyme transglutaminase 5. This enzyme is essential for forming the cornified cell envelope, a structure that surrounds epidermal cells and provides a protective barrier for the skin. Variants in TGM5 reduce or eliminate the activity of this enzyme, weakening the skin's protective barrier and causing the outermost cells to separate and peel off easily.

Inheritance

Peeling skin syndrome 2 is inherited in an autosomal recessive pattern. This means that both copies of the TGM5 gene in each cell must have a variant for the disorder to occur. Parents of an affected individual each carry one copy of the altered gene but do not typically exhibit symptoms of the condition.

Frequently Asked Questions

If peeling is accompanied by pain, signs of infection (redness, warmth, pus), persistent itching that interferes with sleep, or if the skin does not heal within a week, medical evaluation is needed. Also, if peeling spreads rapidly to large body areas or occurs after a new product or medication, a clinician should assess for secondary causes.
blood or saliva sample is sent for sequencing of the TGM5 gene. If two pathogenic variants are identified, the diagnosis is confirmed. Because the disorder is autosomal recessive, parents are typically carriers; testing them can clarify recurrence risk for future children. Siblings have a 25 % chance of being affected and a 50 % chance of being carriers, so carrier testing is advisable if the family plans more children.
While there is no cure, topical agents that boost transglutaminase activity are under investigation. Currently, the most effective approach is regular use of barrier‑enhancing moisturizers, occasional short courses of low‑potency topical steroids for inflammation, and, in severe cases, oral retinoids prescribed by a dermatologist to normalize epidermal turnover.
Gentle, fragrance‑free cleansers applied with lukewarm water are best; avoid hot showers and harsh scrubbing. After washing, pat the skin dry and immediately apply a thick, barrier‑repair moisturizer containing ceramides or petrolatum to lock in moisture. Wearing cotton socks and gloves in humid or sweaty conditions, and using breathable footwear, helps minimize friction‑induced peeling.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ